Behind the Scenes of Edwards Lifesciences's Latest Options TrendsBenzinga • 7 days ago
read more...
Share to Feed
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at...
read more...
Latest Ratings for EW
DateFirmActionFromTo Feb 2022UBSUpgradesNeutralBuy Jan 2022Morgan StanleyMaintainsOverweight Jan 2022Raymond JamesMaintainsOutperform
View More Analyst Ratings for EW...
Edwards Lifesciences (NYSE: EW) announced the release of data from the HUDDLE study that examined the prevalence of heart disease and associated risk factors among members of the National Football...
Edwards Lifesciences (NYSE:EW - Get Free Report) had its price objective boosted by Evercore ISI from $86.00 to $92.00 in a research report issued to clients and investors on Thursday, Benzinga...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
read more...
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...
OTR Global upgraded shares of Edwards Lifesciences (NYSE:EW - Free Report) from a mixed rating to a positive rating in a research report released on Tuesday, Benzinga reports.
EW has been the topic...